PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.54%
Revenue decline while AVGO shows 0.59% growth. Joel Greenblatt would examine competitive position erosion.
-2.55%
Cost reduction while AVGO shows 0.75% growth. Joel Greenblatt would examine competitive advantage.
-7.90%
Gross profit decline while AVGO shows 0.51% growth. Joel Greenblatt would examine competitive position.
-3.53%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-0.72%
R&D reduction while AVGO shows 19.53% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.31%
Operating expenses reduction while AVGO shows 12.43% growth. Joel Greenblatt would examine advantage.
-2.81%
Total costs reduction while AVGO shows 6.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
1.19%
D&A growth less than half of AVGO's 4313.59%. David Dodd would verify if efficiency is sustainable.
-6.99%
EBITDA decline while AVGO shows 62.84% growth. Joel Greenblatt would examine position.
-2.57%
EBITDA margin decline while AVGO shows 61.89% growth. Joel Greenblatt would examine position.
-38.53%
Both companies show declining income. Martin Whitman would check industry conditions.
-35.61%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-1574.42%
Other expenses reduction while AVGO shows 3.38% growth. Joel Greenblatt would examine advantage.
-473.03%
Both companies show declining income. Martin Whitman would check industry conditions.
-490.76%
Both companies show margin pressure. Martin Whitman would check industry conditions.
161.11%
Tax expense growth less than half of AVGO's 1023.08%. David Dodd would verify if advantage is sustainable.
-413.30%
Both companies show declining income. Martin Whitman would check industry conditions.
-428.19%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-427.27%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-427.27%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-4.63%
Share count reduction while AVGO shows 0.26% change. Joel Greenblatt would examine strategy.
-4.63%
Both companies reducing diluted shares. Martin Whitman would check patterns.